M. Llewelyn

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

K. Y. Wong, Mohammad A. Qayum, John S. Clouston, 2022, Lancet.

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

K. Y. Wong, Beverley E. Crane, Scott M Elliott, 2021, Lancet.

Evidence of quality of life for hospitalised patients with COVID-19: a scoping review.

Edward J. D. Webb, Natalie King, P. Pallmann, 2024, Health technology assessment.

Distinct patterns of vital sign and inflammatory marker responses in adults with suspected bloodstream infection.

Qing Gu, M. Llewelyn, Koen B. Pouwels, 2024, The Journal of infection.

Postoperative Staphylococcus aureus Infections in Patients With and Without Preoperative Colonization

P. Barbadoro, F. Coenjaerts, B. Xavier, 2023, JAMA network open.

Developing a model for decision-making around antibiotic prescribing for patients with COVID-19 pneumonia in acute NHS hospitals during the first wave of the COVID-19 pandemic: qualitative results from the Procalcitonin Evaluation of Antibiotic use in COVID-19 Hospitalised patients (PEACH Study)

T. Szakmany, P. Pallmann, E. Carrol, 2023, BMJ Open.